Assignee
XINTHERA INC
US·12 granted patents·8 pending applications·24 citations·filing 2022–2024
Top patents by PatentIndex Score
20 records- 0196US11795173B1Substituted pyridines as PARP1 inhibitorsXINTHERA INC·Filed 2023·Granted Oct 24, 2023·5 cites·18 claims
- 0296US11591331B2PARP1 inhibitors and uses thereofXINTHERA INC·Filed 2022·Granted Feb 28, 2023·6 cites·21 claims
- 0395US12006322B2Substituted pyridines as PARP1 inhibitorsXINTHERA INC·Filed 2023·Granted Jun 11, 2024·2 cites·4 claims
- 0495US11680056B2MK2 inhibitors and uses thereofXINTHERA INC·Filed 2022·Granted Jun 20, 2023·3 cites·28 claims
- 0594US11802128B2Azetidine and pyrrolidine PARP1 inhibitors and uses thereofXINTHERA INC·Filed 2023·Granted Oct 31, 2023·3 cites·15 claims
- 0694US11685719B2Pyridinone MK2 inhibitors and uses thereofXINTHERA INC·Filed 2022·Granted Jun 27, 2023·3 cites·30 claims
- 0793US11939329B2PARP1 inhibitors and uses thereofXINTHERA INC·Filed 2023·Granted Mar 26, 2024·2 cites·5 claims
- 0885US12421241B2Substituted pyridines as PARP1 inhibitorsXINTHERA INC·Filed 2024·Granted Sep 23, 2025·0 cites·4 claims
- 0982US11987574B2MK2 inhibitors and uses thereofXINTHERA INC·Filed 2023·Granted May 21, 2024·0 cites·22 claims
- 1079US12384780B2PARP1 inhibitors and uses thereofXINTHERA INC·Filed 2024·Granted Aug 12, 2025·0 cites·2 claims
- 1177US12545662B2MK2 inhibitors and uses thereofXINTHERA INC·Filed 2023·Granted Feb 10, 2026·0 cites·27 claims
- 1277US12139462B2Pyridinone MK2 inhibitors and uses thereofXINTHERA INC·Filed 2023·Granted Nov 12, 2024·0 cites·30 claims
- 1369US2023159525A1Azetidine and pyrrolidine parp1 inhibitors and uses thereofXINTHERA INC·Filed 2022·Application pending·0 cites
- 1468US2023128041A1Parp1 inhibitors and uses thereofXINTHERA INC·Filed 2022·Application pending·0 cites
- 1565US2024279214A1Alpha4 beta7 inegrin antagonists and uses thereofXINTHERA INC·Filed 2023·Application pending·0 cites
- 1663US2024182449A1Crystalline forms of an mk2 inhibitorXINTHERA INC·Filed 2023·Application pending·0 cites
- 1762US2024174669A1Crystalline forms of a parp1 inhibitorXINTHERA INC·Filed 2023·Application pending·0 cites
- 1862US2025171418A1Parp1 inhibitors and uses thereofXINTHERA INC·Filed 2023·Application pending·0 cites
- 1961US2026098024A1Parp1 inhibitors and uses thereofXINTHERA INC·Filed 2023·Application pending·0 cites
- 2056US2024317746A1Crystalline forms of an azetidine parp1 inhibitorXINTHERA INC·Filed 2024·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when XINTHERA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →